secwatch.observer — SEC 8-K summary
======================================

Issuer:     iSpecimen Inc. (ISPC)
CIK:        0001558569
Form:       8-K
Filed at:   2025-11-03T23:59:59+00:00
Accession:  0001213900-25-104942
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

iSpecimen stockholders approve reverse stock split, authorized share increase, and equity line of credit
--------------------------------------------------------------------------------

- Reverse stock split approved at ratio from 1:10 to 1:100; Board to set exact ratio.
- Authorized shares increased from 250M to 1B; 1,370,770 voted for.
- Private financings up to >19.99% of shares at sub-minimum price approved for Nasdaq compliance.
- Convertible securities amended to raise conversion price floor from 50% to 80% of lowest VWAP.
- Equity line of credit approved allowing issuance >19.99% of shares at below-minimum price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1558569/000121390025104942/0001213900-25-104942-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1558569/000121390025104942/ea0263543-8k_ispecimen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-104942

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer